Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome

Pediatric Research

Volumn 60, Issue 2, 2006, Pages 225-230

  Verkauskiene, Rasa ^a   Dollfus, Catherine ^b   Levine, Martine ^a   Faye, Albert ^a   Deghmoun, Samia ^a   Houang, Muriel ^b   Chevenne, Didier ^a   Bresson, Jean Louis ^c   Blanche, Stéphane ^c   Lévy Marchal, Claire ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIRETROVIRUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY FAT DISTRIBUTION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOCRINE FUNCTION; FAT REDISTRIBUTION SYNDROME; FEMALE; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIPID ANALYSIS; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; PUBERTY; SEX RATIO; STATISTICAL SIGNIFICANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADIPONECTIN; ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DYSLIPIDEMIAS; EARLY DIAGNOSIS; FEMALE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE;

EID: 33748051437     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000228335.64894.26     Document Type: Article

References (41)

1. Jaquet D, Levine M, Ortega-Rodriguez E, Faye A, Polak M, Vilmer E, Levy-Marchal C 2000 Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS 14:2123-2128
2. Arpadi SM, Cuff PA, Horlick M, Wang J, Kotler DP 2001 Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine. J Acquir Immune Defic Syndr 27:30-34
3. Taylor P, Worrell C, Steinberg SM, Hazra R, Jankelevich S, Wood LV, Zwerski S, Yarchoan R, Zeichner S 2004 Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics 114:e235-242
4. Vigano A, Mora S, Testolin C, Beccio S, Schneider L, Bricalli D, Vanzulli A, Manzoni P, Brambilla P 2003 Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children. J Acquir Immune Defic Syndr 32:482-489
5. European Paediatric Lipodystrophy Group 2004 Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 18:1443-1451.
6. Beregszaszi M, Jaquet D, Levine M, Ortega-Rodriguez E, Baltakse V, Polak M, Levy-Marchal C 2003 Severe insulin resistance contrasting with mild anthropometric changes in the adipose tissue of HIV-infected children with lipohypertrophy. Int J Obes Relat Metab Disord 27:25-30
7. Mallon PW, Unemori P, Sedwell R, Morey A, Rafferty M, Williams K, Chisholm D, Samaras K, Emery S, Kelleher A, Cooper DA, Carr A, 2005 A In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J Infect Dis 191:1686-1696
8. Madge S, Kinloch-de-Loes S, Mercey D, Johnson MA, Weller IV 1999 Lipodystrophy in patients naive to HIV protease inhibitors. AIDS 13:735-737
9. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA 1998 A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51-58
10. Nolan D, John M, Mallal S 2001 Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis. Antivir Ther 6:145-160
11. Havel PJ 2004 Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53(Suppl 1):S143-S151
12. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A, 2002 A leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570-578
13. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI 2002 Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345-1350
14. Haque WA, Shimomura I, Matsuzawa Y, Garg A, 2002 Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87:2395
15. Vigouroux C, Maachi M, Nguyen TH, Coussieu C, Gharakhanian S, Funahashi T, Matsuzawa Y, Shimomura I, Rozenbaum W, Capeau J, Bastard JP 2003 Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS 17:1503-1511
16. Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS 2003 Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab 88:627-636
17. Tong Q, Sankale JL, Hadigan CM, Tan G, Rosenberg ES, Kanki PJ, Grinspoon SK, Hotamisligil GS 2003 Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices. J Clin Endocrinol Metab 88:1559-1564
18. Mynarcik DC, Combs T, McNurlan MA, Scherer PE, Komaroff E, Gelato MC 2002 Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution. J Acquir Immune Defic Syndr 31:514-520
19. Weiss R, Dufour S, Groszmann A, Petersen K, Dziura J, Taksali SE, Shulman G, Caprio S 2003 Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 88:2014-2018
20. Diamond FB Jr, Cuthbertson D, Hanna S, Eichler D 2004 Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab 17:1069-1075
21. Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakane T, Kodera K, Shirahata A, Taniyama M 2003 Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 11:1072-1079
22. Ogawa Y, Kikuchi T, Nagasaki K, Hiura M, Tanaka Y, Uchiyama M 2005 Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res 28:51-57
23. Beregszaszi M, Dollfus C, Levine M, Faye A, Deghmoun S, Bellal N, Houang M, Chevenne D, Hankard R, Bresson JL, Blanche S, Levy-Marchal C 2005 Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children. J Acquir Immune Defic Syndr 40:161-168
24. Tanner JM 1986 Normal growth and techniques of growth assessment. Clin Endocrinol Metab 15:411-451
25. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A, 1991 A body mass index variation: centiles from birth to 87 years. Eur J Clin Nutr 45:13-21
26. Schwenk A, Beisenherz A, Kremer G, Diehl V, Salzberger B, Fatkenheuer G 1999 Bioelectrical impedance analysis in HIV-infected patients treated with triple anti-retroviral treatment. Am J Clin Nutr 70:867-873
27. Rolland-Cachera MF, Bellisle F, Deheeger M, Pequignot F, Sempe M 1990 Influence of body fat distribution during childhood on body fat distribution in adulthood: a two-decade follow-up study. Int J Obes 14:473-481
28. Centers for Disease Control and Prevention 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age; Official authorized addenda: human immunodeficiency virus infection codes and official guidelines for coding and reporting ICD-9-CM. MMWR 43:1-10.
29. Christensen B, Glueck C, Kwiterovich P, Degroot I, Chase G, Heiss G, Mowery R, Tamir I, Rifkind B 1980 Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the Prevalence Study of the Lipid Research Clinics Program. Pediatr Res 14:194-202
30. Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG 2003 An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 361:726-735
31. Ravussin E, Smith SR 2002 Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 967:363-378
32. Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC 2000 Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr 25:312-321
33. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L 2001 Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881
34. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
35. Ravussin E 2002 Adiponectin enhances insulin action by decreasing ectopic fat deposition. Pharmacogenomics J 2:4-7
36. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE 2003 Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-469
37. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Haring H, Stumvoll M 2003 Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239-243
38. Paganelli R, Mezzaroma I, Mazzone AM, Pinter E, Aiuti F 1999 Leptin levels in HIV-positive patients treated with HAART. AIDS 13:2479-
39. Estrada V, Serrano-Rios M, Martinez Larrad MT, Villar NG, Gonzalez Lopez A, Tellez MJ, Fernandez C 2002 Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy. J Acquir Immune Defic Syndr 29:32-40
40. Mackintosh RM, Hirsch J 2001 The effects of leptin administration in non-obese human subjects. Obes Res 9:462-469
41. Campbell IW 2005 The clinical significance of PPAR gamma agonism. Curr Mol Med 5:349-363